Tokushima, Japan

Junko Yamashita



 

Average Co-Inventor Count = 22.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Junko Yamashita: Innovator in Pharmaceutical Compounds

Introduction

Junko Yamashita is a prominent inventor based in Tokushima, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as monoamines reuptake inhibitors. With a total of 5 patents to her name, her work has the potential to impact therapeutic practices significantly.

Latest Patents

One of her latest patents involves N,N-substituted 3-aminopyrrolidine compounds that are useful as monoamines reuptake inhibitors. The invention provides a pyrrolidine compound of General Formula (1) or a salt thereof, where R and R' are each independently a phenyl group or a pyridyl group. These groups may have one or more substituents selected from halogen atoms and lower alkyl groups, which can also be optionally substituted with halogen atoms. The pyrrolidine compound or a salt thereof is designed to produce a pharmaceutical preparation that has a wider therapeutic spectrum and can exhibit sufficient therapeutic effects after short-term administration.

Career Highlights

Junko Yamashita is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues to innovate and develop new pharmaceutical solutions. Her work is characterized by a commitment to enhancing therapeutic options for patients.

Collaborations

Throughout her career, Junko has collaborated with notable colleagues, including Muneaki Kurimura and Shinichi Taira. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Junko Yamashita stands out as a significant figure in the pharmaceutical industry, with her innovative patents paving the way for new therapeutic options. Her contributions are vital to the ongoing development of effective treatments in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…